{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:27:59Z","timestamp":1761845279689,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s12350-020-02390-z","type":"journal-article","created":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T14:02:32Z","timestamp":1603288952000},"page":"978-986","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prognostic value of absent left ventricular ejection fraction reserve with regadenoson SPECT MPI"],"prefix":"10.1016","volume":"29","author":[{"given":"Phillip","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman","family":"Farag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradeep","family":"Bhambhvani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ami","family":"Iskandrian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadi G.","family":"Hage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s12350-020-02390-z_bib1","doi-asserted-by":"crossref","unstructured":"2013 Nuclear Cardiology Trend Survey. J Nucl Cardiol 2014;21:S5-88.","DOI":"10.1007\/s12350-014-9862-z"},{"key":"10.1007\/s12350-020-02390-z_bib2","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s12350-014-9922-4","article-title":"Regadenoson for myocardial perfusion imaging: Is it safe?","volume":"21","author":"Hage","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02390-z_bib3","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1007\/s12350-014-0050-y","article-title":"The prognostic value of regadenoson myocardial perfusion imaging","volume":"22","author":"Hage","year":"2015","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02390-z_bib4","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jcmg.2012.04.009","article-title":"Comparison of the prognostic value of normal regadenoson with normal adenosine myocardial perfusion imaging with propensity score matching","volume":"5","author":"Iqbal","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1007\/s12350-020-02390-z_bib5","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1007\/s12350-012-9593-y","article-title":"Prognosis in the era of comparative effectiveness research: where is nuclear cardiology now and where should it be?","volume":"19","author":"Shaw","year":"2012","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02390-z_bib6","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.nuclcard.2007.06.114","article-title":"Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial","volume":"14","author":"Iskandrian","year":"2007","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02390-z_bib7","doi-asserted-by":"crossref","unstructured":"Cerqueira MD, Nguyen P, Staehr P, Underwood SR, Iskandrian AE, Investigators A-MT. Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results. JACC Cardiovasc Imaging 2008;1:307-16.","DOI":"10.1016\/j.jcmg.2008.02.003"},{"key":"10.1007\/s12350-020-02390-z_bib8","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1007\/s12350-015-0155-y","article-title":"Comparison of the prognostic value of regadenoson and adenosine myocardial perfusion imaging","volume":"22","author":"Farzaneh-Far","year":"2015","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02390-z_bib9","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s12350-012-9661-3","article-title":"Regadenoson: a focused update","volume":"20","author":"Ghimire","year":"2013","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02390-z_bib10","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s12350-016-0441-3","article-title":"The prognostic value of non-perfusion variables obtained during vasodilator stress myocardial perfusion imaging","volume":"23","author":"Bajaj","year":"2016","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02390-z_bib11","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1007\/s12350-011-9429-1","article-title":"A blunted heart rate response to regadenoson is an independent prognostic indicator in patients undergoing myocardial perfusion imaging","volume":"18","author":"Hage","year":"2011","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02390-z_bib12","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s12350-015-0269-2","article-title":"Heart rate response to regadenoson: Making the case for its value in clinical practice","volume":"23","author":"Andrikopoulou","year":"2016","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02390-z_bib13","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s12350-017-1115-5","article-title":"Additional value of systolic wall thickening in myocardial stunning evaluated by stress-rest gated perfusion SPECT","volume":"26","author":"Bestetti","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02390-z_bib14","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s12350-017-1127-1","article-title":"Myocardial stunning by gated SPECT: An old tool reinvented in a stunning turn","volume":"26","author":"AlJaroudi","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02390-z_bib15","first-page":"349","article-title":"Value of vasodilator left ventricular ejection fraction reserve in evaluating the magnitude of myocardium at risk and the extent of angiographic coronary artery disease: a 82Rb PET\/CT study","volume":"48","author":"Dorbala","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-020-02390-z_bib16","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s12350-017-0802-6","article-title":"The significance of post-stress decrease in left ventricular ejection fraction in patients undergoing regadenoson stress gated SPECT myocardial perfusion imaging","volume":"25","author":"Gomez","year":"2018","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02390-z_bib17","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s12350-015-0272-7","article-title":"Prognostic value of transient ischemic dilation with regadenoson myocardial perfusion imaging","volume":"23","author":"Lester","year":"2016","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02390-z_bib18","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s12350-015-0387-x","article-title":"ASNC imaging guidelines for SPECT nuclear cardiology procedures: Stress, protocols, and tracers","volume":"23","author":"Henzlova","year":"2016","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02390-z_bib19","first-page":"2138","article-title":"Automatic quantification of ejection fraction from gated myocardial perfusion SPECT","volume":"36","author":"Germano","year":"1995","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-020-02390-z_bib20","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1007\/s12350-014-9983-4","article-title":"Detection of post-exercise stunning by early gated SPECT myocardial perfusion imaging: results from the IAEA multi-center study","volume":"21","author":"Mut","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02390-z_bib21","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s12350-016-0519-y","article-title":"Quantitation of left ventricular ejection fraction reserve from early gated regadenoson stress Tc-99 m high-efficiency SPECT","volume":"23","author":"Brodov","year":"2016","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02390-z_bib22","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s12350-015-0087-6","article-title":"The significance of automatically measured transient ischemic dilation in identifying severe and extensive coronary artery disease in regadenoson, single-isotope technetium-99m myocardial perfusion SPECT","volume":"22","author":"Golzar","year":"2015","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02390-z_bib23","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1007\/s12350-013-9765-4","article-title":"The prognostic value of transient ischemic dilatation with otherwise normal SPECT myocardial perfusion imaging: a cautionary note in patients with diabetes and coronary artery disease","volume":"20","author":"Doukky","year":"2013","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02390-z_bib24","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s12350-017-1040-7","article-title":"Diagnostic and prognostic significance of transient ischemic dilation (TID) in myocardial perfusion imaging: A systematic review and meta-analysis","volume":"25","author":"Alama","year":"2018","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02390-z_bib25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12350-012-9642-6","article-title":"Transient ischemic dilation in SPECT myocardial perfusion imaging for prediction of severe coronary artery disease in diabetic patients","volume":"20","author":"Petretta","year":"2013","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02390-z_bib26","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1007\/s12350-016-0515-2","article-title":"Computer derived transient ischemic dilation ratio for identifying extensive coronary artery disease using a CZT camera and imaging in the upright position","volume":"24","author":"Jameria","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02390-z_bib27","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/0002-9149(79)90148-6","article-title":"Multiple gated cardiac blood pool imaging for left ventricular ejection fraction: validation of the technique and assessment of variability","volume":"43","author":"Wackers","year":"1979","journal-title":"Am J Cardiol."},{"key":"10.1007\/s12350-020-02390-z_bib28","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1007\/s12350-014-9899-z","article-title":"Segmental and global left ventricular function assessment using gated SPECT with a semiconductor Cadmium Zinc Telluride (CZT) camera: phantom study and clinical validation vs cardiac magnetic resonance","volume":"21","author":"Bailliez","year":"2014","journal-title":"J Nucl Cardiol."}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-020-02390-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12350-020-02390-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123003422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123003422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-020-02390-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:11:01Z","timestamp":1761027061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358123003422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1071358123003422"],"URL":"https:\/\/doi.org\/10.1007\/s12350-020-02390-z","relation":{},"ISSN":["1071-3581"],"issn-type":[{"type":"print","value":"1071-3581"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic value of absent left ventricular ejection fraction reserve with regadenoson SPECT MPI","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-020-02390-z","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}